Displaying publications 21 - 40 of 8649 in total

Abstract:
Sort:
  1. Ahmad Zaki R, Xin NZ
    Asia Pac J Public Health, 2023 Jan;35(1):62-64.
    PMID: 36341513 DOI: 10.1177/10105395221134655
    Matched MeSH terms: Malaysia/epidemiology
  2. Aziz NA, Othman J, Lugova H, Suleiman A
    J Infect Public Health, 2020 Dec;13(12):1823-1829.
    PMID: 32896496 DOI: 10.1016/j.jiph.2020.08.007
    Malaysia recorded its first case of COVID-19 on January 24th, 2020 with a stable number of reported cases until March 2020, where there was an exponential spike due to a massive religious gathering in Kuala Lumpur. This caused Malaysia to be the hardest hit COVID-19 country in South East Asia at the time. In order to curb the transmission and better managed the clusters, Malaysia imposed the Movement Control Order (MCO) which is now in its fourth phase. The MCO together with targeted screening have slowed the spread of COVID-19 epidemic. The government has also provided three economic stimulus packages in order to cushion the impact of the shrinking economy. Nonetheless, early studies have shown that the MCO would greatly affect the lower and medium income groups, together with small and medium businesses.
    Matched MeSH terms: Malaysia/epidemiology
  3. Wu X, Yong CC, Lee ST
    Int J Environ Res Public Health, 2022 Nov 25;19(23).
    PMID: 36497744 DOI: 10.3390/ijerph192315669
    In 2020, coronavirus disease (COVID-19) left around 81% of the global workforce, nearly 2.7 billion workers, affected. Employment in China was the first to be hit by COVID-19. The Regional Comprehensive Economic Partnership (RCEP) is expected to bring dynamism to China's employment market in an era of long COVID-19. This study aims to examine the number of sectoral jobs that the RCEP will create in China, with the number of skilled or unskilled labour employed in each sector. The exogenous shocks to the RCEP can be reflected in the number of jobs created through multipliers based on a social accounting matrix compiled from China's input-output tables in 2017, combined with the employment satellite accounts compiled. The results show that the RCEP is expected to create over 17 million potential jobs in China, with unskilled labour accounting for 10.44 million and skilled labour for 6.77 million. It is even expected that there will be job losses in the metalworking machinery sector. The contribution of this paper can serve as a reference for policies to protect vulnerable sectors, further open up trade markets and strengthen cooperation among RCEP members as important measures to address the employment impact of long COVID-19.
    Matched MeSH terms: China/epidemiology
  4. Wong MTJ, Dhaliwal SS, Balakrishnan V, Nordin F, Norazmi MN, Tye GJ
    PMID: 36674401 DOI: 10.3390/ijerph20021647
    (1) Background: The assessment of vaccine effectiveness against the Omicron variant is vital in the fight against COVID-19, but research on booster vaccine efficacy using nationwide data was lacking at the time of writing. This study investigates the effectiveness of booster doses on the Omicron wave in Malaysia against COVID-19 infections and deaths; (2) Methods: This study uses nationally representative data on COVID-19 from 1 January to 31 March 2022, when the Omicron variant was predominant in Malaysia. Daily new infections, deaths, ICU utilization and Rt values were compared. A screening method was used to predict the vaccine effectiveness against COVID-19 infections, whereas logistic regression was used to estimate vaccine effectiveness against COVID-19-related deaths, with efficacy comparison between AZD1222, BNT162b2 and CoronaVac; (3) Results: Malaysia's Omicron wave started at the end of January 2022, peaking on 5 March 2022. At the time of writing, statistics for daily new deaths, ICU utilization, and effective reproductive values (Rt) were showing a downtrend. Boosted vaccination is 95.4% (95% CI: 95.4, 95.4) effective in curbing COVID-19 infection, compared to non-boosted vaccination, which is 87.2% (95% CI: 87.2, 87.2). For symptomatic infection, boosted vaccination is 97.4% (95% CI: 97.4, 97.4) effective, and a non-boosted vaccination is 90.9% (95% CI: 90.9, 90.9). Against COVID-19-related death, boosted vaccination yields a vaccine effectiveness (VE) of 91.7 (95% CI: 90.6, 92.7) and full vaccination yields a VE of 65.7% (95% CI: 61.9, 69.1). Looking into the different vaccines as boosters, AZD1222 is 95.2% (CI 95%: 92.7, 96.8) effective, BNT162b2 is 91.8% (CI 95%: 90.7, 92.8) effective and CoronaVac is 88.8% (CI 95%: 84.9, 91.7) effective against COVID-19 deaths. (4) Conclusions: Boosters are effective in increasing protection against COVID-19, including the Omicron variant. Given that the VE observed was lower, CoronaVac recipients are encouraged to take boosters due to its lower VE.
    Matched MeSH terms: Malaysia/epidemiology
  5. Kalra S, Dhar M, Afsana F, Aggarwal P, Aye TT, Bantwal G, et al.
    Rev Diabet Stud, 2022 Jun 30;18(2):100-134.
    PMID: 35831938 DOI: 10.1900/RDS.2022.18.100
    The elderly population with diabetes is diverse with the majority experiencing a decline in physical and mental capabilities, impacting the entire diabetes management process. Therefore, a need for geriatric-specific guidelines, especially for the Asian population, was identified and subsequently developed by an expert panel across government and private institutions from several Asian countries. The panel considered clinical evidence (landmark trials, position papers, expert opinions), recommendations from several important societies along with their decades of clinical experience and expertise, while meticulously devising thorough geriatric-specific tailored management strategies. The creation of the ABCDE best practices document underscores and explores the gaps and challenges and determines optimal methods for diabetes management of the elderly population in the Asian region.
    Matched MeSH terms: Asia/epidemiology
  6. Tse E, Kwong YL, Goh YT, Bee PC, Ng SC, Tan D, et al.
    Clin Exp Med, 2023 Oct;23(6):2895-2907.
    PMID: 36795237 DOI: 10.1007/s10238-023-01007-2
    In recent years, considerable progress has been made in the standard treatment for chronic lymphocytic leukaemia (CLL) due to the availability of new potent drugs. However, the majority of data on CLL were derived from Western populations, with limited studies and guidelines on the management of CLL from an Asian population perspective. This consensus guideline aims to understand treatment challenges and suggest appropriate management approaches for CLL in the Asian population and other countries with a similar socio-economic profile. The following recommendations are based on a consensus by experts and an extensive literature review and contribute towards uniform patient care in Asia.
    Matched MeSH terms: Asia/epidemiology
  7. Baker HJ
    Mil Med, 1965 Nov;130(11):1101-2.
    PMID: 4953542
    Matched MeSH terms: Leptospirosis/epidemiology*
  8. Tok PSK, Kamarudin N', Jamaludin M, Ab Razak MF, Ahmad MAS, Abu Bakar FA, et al.
    Infect Dis (Lond), 2022 Mar;54(3):235-237.
    PMID: 34772327 DOI: 10.1080/23744235.2021.2000636
    Matched MeSH terms: Malaysia/epidemiology
  9. Singh V, De A, Mehtani R, Angeli P, Maiwall R, Satapathy S, et al.
    Hepatol Int, 2023 Aug;17(4):792-826.
    PMID: 37237088 DOI: 10.1007/s12072-023-10536-7
    Matched MeSH terms: Asia/epidemiology
  10. Jatuworapruk K, De Vera R, Estrella AM, Sollano MHMZ, Vaidya B, Rahman MM, et al.
    Int J Rheum Dis, 2023 Aug;26(8):1432-1434.
    PMID: 37527022 DOI: 10.1111/1756-185X.14765
    Matched MeSH terms: Asia/epidemiology
  11. Abd Gani SM, Alied M, Huy NT
    J Glob Health, 2023 Dec 22;13:03063.
    PMID: 38126904 DOI: 10.7189/jogh.13.03063
    Matched MeSH terms: Malaysia/epidemiology
  12. Fletcher W
    Matched MeSH terms: Epidemiology
  13. El Guerche-Séblain C, Rigoine De Fougerolles T, Sampson K, Jennings L, Van Buynder P, Shu Y, et al.
    BMC Public Health, 2021 09 26;21(1):1750.
    PMID: 34563151 DOI: 10.1186/s12889-021-11765-x
    BACKGROUND: The Western Pacific Region (WPR) is exposed each year to seasonal influenza and is often the source of new influenza virus variants and novel pathogen emergence. National influenza surveillance systems play a critical role in detecting emerging viruses, monitoring influenza epidemics, improving public disease awareness and promoting pandemic preparedness, but vary widely across WPR countries. The aim of this study is to improve existing influenza surveillance systems by systematically comparing selected WPR influenza surveillance systems.

    METHODS: Three national influenza surveillance systems with different levels of development (Australia, China and Malaysia) were compared and their adherence to World Health Organization (WHO) guidance was evaluated using a structured framework previously tested in several European countries consisting of seven surveillance sub-systems, 19 comparable outcomes and five evaluation criteria. Based on the results, experts from the Asia-Pacific Alliance for the Control of Influenza (APACI) issued recommendations for the improvement of existing surveillance systems.

    RESULTS: Australia demonstrated the broadest scope of influenza surveillance followed by China and Malaysia. In Australia, surveillance tools covered all sub-systems. In China, surveillance did not cover non-medically attended respiratory events, primary care consultations, and excess mortality modelling. In Malaysia, surveillance consisted of primary care and hospital sentinel schemes. There were disparities between the countries across the 5 evaluation criteria, particularly regarding data granularity from health authorities, information on data representativeness, and data communication, especially the absence of publicly available influenza epidemiological reports in Malaysia. This dual approach describing the scope of surveillance and evaluating the adherence to WHO guidance enabled APACI experts to make a number of recommendations for each country that included but were not limited to introducing new surveillance tools, broadening the use of specific existing surveillance tools, collecting and sharing data on virus characteristics, developing immunization status registries, and improving public health communication.

    CONCLUSIONS: Influenza monitoring in Australia, China, and Malaysia could benefit from the expansion of existing surveillance sentinel schemes, the broadened use of laboratory confirmation and the introduction of excess-mortality modelling. The results from the evaluation can be used as a basis to support expert recommendations and to enhance influenza surveillance capabilities.

    Matched MeSH terms: Australia/epidemiology; China/epidemiology; Malaysia/epidemiology
  14. Ladner J, Madi F, Jayasundera R, Saba J, Audureau E
    J Comp Eff Res, 2023 Jul;12(7):e220210.
    PMID: 37278943 DOI: 10.57264/cer-2022-0210
    Aim: Survival of patients with Hodgkin's lymphoma is lower in in low- and middle-income countries, but factors leading to these outcomes are poorly understood. The objective of this study was to identify predictive factors associated with overall survival among cancer patients undergoing therapy in seven low- and middle-income countries. Materials & methods: A multicenter cohort was conducted in Egypt, Malaysia, Mexico, Peru, Philippines, Thailand and Ukraine. Results. A total of 460 patients were included. Phone-based support during patient follow-up and number of patients seen by the physician provided a positive impact, while the number of adverse events remains a predictor of death and physician decision to stop treatment. Conclusion: Furthers research on the potential benefit of phone-based programs to support patients with chronic diseases treatments should be explored in less developed countries.
    Matched MeSH terms: Mexico/epidemiology; Peru/epidemiology; Thailand/epidemiology
  15. Jayaram M
    Med J Malaysia, 2005 Dec;60(5):531-4.
    PMID: 16515101
    Matched MeSH terms: Malaysia/epidemiology; Melioidosis/epidemiology*
  16. J Sykepleien, 1993 Jan 19;81(1):20.
    PMID: 8466793
    Matched MeSH terms: Asia/epidemiology; HIV Infections/epidemiology*
  17. Lim A
    Med J Malaysia, 1991 Jun;46(2):114-5.
    PMID: 1839413
    Matched MeSH terms: Malaysia/epidemiology; Neoplasms/epidemiology*
  18. Ramanathan K
    Dent J Malaysia Singapore, 1972 May;12(1):3-8.
    PMID: 4507357
    Matched MeSH terms: Carcinoma, Squamous Cell/epidemiology; Mouth Neoplasms/epidemiology
  19. GRIFFITH DH, MAURER SP, CHOO LS
    Med J Malaya, 1957 Sep;12(1):348-72.
    PMID: 13492807
    Matched MeSH terms: Filariasis/epidemiology*; Malaria/epidemiology*
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links